Imaging tests that create pictures of your internal organs. These tests help your doctors visualize your internal organs, including the pancreas. Techniques used to diagnose pancreatic cancer include ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and, sometimes, positron emission tomography (PET) scans.
This report contains market size and forecasts of Pancreatic Cancer Diagnostic Devices in Global, including the following market information:
- Global Pancreatic Cancer Diagnostic Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pancreatic Cancer Diagnostic Devices market was valued at 5879.4 million in 2021 and is projected to reach US$ 9344.2 million by 2028, at a CAGR of 6.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Imaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pancreatic Cancer Diagnostic Devices include Roche, GE Healthcare, Siemens, BD, Philips Healthcare, Hitachi Medical, Danaher, Abbott and Canon Medical Systems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pancreatic Cancer Diagnostic Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pancreatic Cancer Diagnostic Devices Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pancreatic Cancer Diagnostic Devices Market Segment Percentages, by Type, 2021 (%)
- Imaging
- Tumor Biomarker
- Biopsy
- Others
Global Pancreatic Cancer Diagnostic Devices Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pancreatic Cancer Diagnostic Devices Market Segment Percentages, by Application, 2021 (%)
Global Pancreatic Cancer Diagnostic Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pancreatic Cancer Diagnostic Devices Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Pancreatic Cancer Diagnostic Devices revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Pancreatic Cancer Diagnostic Devices revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Roche
- GE Healthcare
- Siemens
- BD
- Philips Healthcare
- Hitachi Medical
- Danaher
- Abbott
- Canon Medical Systems
- Myriad Genetics
- Qiagen
- Asuragen
- BioMarker Strategies
